GT Biopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GT Biopharma and other ETFs, options, and stocks.About GTBP
GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of the immuno-oncology therapeutic products based proprietary TriKE NK cell engager platform. The TriKE platform is designed to harness and enhance the cancer killing abilities of a patient's immune system natural killer cells (NK cells).
GTBP Key Statistics
Stock Snapshot
The current GT Biopharma(GTBP) stock price is $0.43, with a market capitalization of 13.47M. The stock trades at a price-to-earnings (P/E) ratio of -0.03.
On 2026-03-19, GT Biopharma(GTBP) stock traded between a low of $0.42 and a high of $0.43. Shares are currently priced at $0.43, which is +2.4% above the low and -1.1% below the high.
The GT Biopharma(GTBP)'s current trading volume is 207.32K, compared to an average daily volume of 605.33K.
In the last year, GT Biopharma(GTBP) shares hit a 52-week high of $3.85 and a 52-week low of $0.39.
In the last year, GT Biopharma(GTBP) shares hit a 52-week high of $3.85 and a 52-week low of $0.39.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.